Belinostat in Treating Patients With Myelodysplastic Syndromes

Clinical trial NCT00357162 · COMPLETED

Trial details

NCT number: NCT00357162
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Secondary Myelodysplastic Syndromes

Start date: 2006-05-01
Primary completion: 2010-12-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.